Save your place

Sign in to WhoBought

Please try again later.

Jim Simons's Vertex Pharmaceuticals Incorporated (VRTX) position

Yes: as of Q1 2026, Jim Simons holds 422K shares of VRTX worth $188M (0.3% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$188M
Shares held
422K
% of portfolio
0.3%
Est. average buy price (i)
$272.17
est. since Q1 2021
Quarter-end price
$446.54

Estimated trade prices

Average price in quarters with purchases
$318.87
Average prices in quarters with sales
  • Q1 2026: $466.52 (83K shares sold)
  • Q4 2025: $430.92 (231K shares sold)
  • Q3 2025: $417.89 (269K shares sold)
  • Q2 2025: $460.83 (167K shares sold)
  • Q1 2025: $466.00 (226K shares sold)
  • Q4 2024: $463.53 (234K shares sold)
  • Q2 2024: $434.05 (14K shares sold)
  • Q1 2024: $422.74 (11K shares sold)
  • Q4 2023: $369.42 (72K shares sold)
  • Q2 2023: $336.94 (126K shares sold)
  • Q1 2023: $299.93 (849K shares sold)
  • Q4 2021: $194.45 (265K shares sold)
  • Q3 2021: $195.24 (386K shares sold)
  • Q2 2021: $209.17 (123K shares sold)

VRTX price vs Simons's position

Dates
$100$200$400$60020222023202420252026Sold 386K shares (16.9%) · Q3 2021. Average closing price $195.24 · Price range $181.39–$202.99386KsharessoldSold 265K shares (14.0%) · Q4 2021. Average closing price $194.45 · Price range $177.01–$223.45265KsharessoldAdded 80K shares (4.9%) · Q1 2022. Average closing price $237.33 · Price range $221.42–$260.9780KsharespurchasedAdded 54K shares (3.2%) · Q2 2022. Average closing price $267.66 · Price range $234.96–$292.5554KsharespurchasedAdded 378K shares (21.4%) · Q3 2022. Average closing price $287.72 · Price range $273.83–$305.53378KsharespurchasedAdded 108K shares (5.0%) · Q4 2022. Average closing price $304.77 · Price range $285.76–$321.48108KsharespurchasedSold 849K shares (37.8%) · Q1 2023. Average closing price $299.93 · Price range $283.23–$323.10849KsharessoldSold 126K shares (9.0%) · Q2 2023. Average closing price $336.94 · Price range $314.42–$351.91126KsharessoldAdded 392K shares (30.8%) · Q3 2023. Average closing price $349.73 · Price range $338.18–$362.46392KsharespurchasedSold 72K shares (4.4%) · Q4 2023. Average closing price $369.42 · Price range $343.00–$410.6872KsharessoldSold 11K shares (0.7%) · Q1 2024. Average closing price $422.74 · Price range $407.69–$446.0811KsharessoldSold 14K shares (0.9%) · Q2 2024. Average closing price $434.05 · Price range $392.81–$485.5314KsharessoldAdded 65K shares (4.2%) · Q3 2024. Average closing price $480.37 · Price range $460.00–$505.7865KsharespurchasedSold 234K shares (14.4%) · Q4 2024. Average closing price $463.53 · Price range $396.64–$516.74234KsharessoldSold 226K shares (16.1%) · Q1 2025. Average closing price $466.00 · Price range $402.49–$513.76226KsharessoldSold 167K shares (14.2%) · Q2 2025. Average closing price $460.83 · Price range $421.16–$509.50167KsharessoldSold 269K shares (26.8%) · Q3 2025. Average closing price $417.89 · Price range $368.03–$479.53269KsharessoldSold 231K shares (31.4%) · Q4 2025. Average closing price $430.92 · Price range $402.90–$463.13231KsharessoldSold 83K shares (16.5%) · Q1 2026. Average closing price $466.52 · Price range $433.07–$499.1783Ksharessold← Earlier —1 sell
Average closing price · filing quarter
$466.52
Price range · filing quarter
$433.07 – $499.17

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −83K −$39M −16.5% 422K May 14, 2026
Q4 2025 Reduced −231K −$99M −31.4% 505K Feb 12, 2026
Q3 2025 Reduced −269K −$112M −26.8% 736K Nov 13, 2025
Q2 2025 Reduced −167K −$77M −14.2% 1.0M Aug 13, 2025
Q1 2025 Reduced −226K −$105M −16.1% 1.2M May 14, 2025
Q4 2024 Reduced −234K −$109M −14.4% 1.4M Feb 13, 2025
Q3 2024 Added +65K +$31M +4.2% 1.6M Nov 13, 2024
Q2 2024 Reduced −14K −$6.1M −0.9% 1.6M Aug 9, 2024
Q1 2024 Reduced −11K −$4.7M −0.7% 1.6M May 13, 2024
Q4 2023 Reduced −72K −$27M −4.4% 1.6M Feb 13, 2024
Q3 2023 Added +392K +$137M +30.8% 1.7M Nov 14, 2023
Q2 2023 Reduced −126K −$42M −9.0% 1.3M Aug 11, 2023
Q1 2023 Reduced −849K −$255M −37.8% 1.4M May 12, 2023
Q4 2022 Added +108K +$33M +5.0% 2.2M Feb 13, 2023
Q3 2022 Added +378K +$109M +21.4% 2.1M Nov 14, 2022
Q2 2022 Added +54K +$14M +3.2% 1.8M Aug 12, 2022
Q1 2022 Added +80K +$19M +4.9% 1.7M May 13, 2022
Q4 2021 Reduced −265K −$51M −14.0% 1.6M Feb 11, 2022
Q3 2021 Reduced −386K −$75M −16.9% 1.9M Nov 12, 2021
Q2 2021 Reduced −123K −$26M −5.1% 2.3M Aug 13, 2021
Q1 2021 First covered 2.4M May 13, 2021
Data through Q1 2026 · filed May 14, 2026
21 grouped rows from 21 quarters

More Simons positions

Common questions

Does Jim Simons own VRTX?

Yes. As of Q1 2026, Jim Simons disclosed 422K shares of VRTX, worth $188M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jim Simons buy VRTX?

Jim Simons held VRTX since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jim Simons sell VRTX?

The quarter-by-quarter table above shows each sale and reduction Jim Simons disclosed in VRTX. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of VRTX does Jim Simons own?

Jim Simons disclosed 422K shares of VRTX as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jim Simons pay for VRTX?

Jim Simons began building the VRTX position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.